Household contact investigation for tuberculosis in Vietnam: study protocol for a cluster randomized controlled trial

Trials

Guy B Marks³  Warwick J Britton¹  Dinh Ngoc Sy²  Nguyen Viet Nhung²  Gregory J Fox⁴ 

[1] Centenary Institute, Newtown, NSW 2042, Australia;National Lung Hospital, Ba Dinh, Hanoi, Vietnam;Liverpool Hospital, Sydney, NSW 2170, Australia;Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia

关键词: Tuberculosis;    Screening;    Pulmonary tuberculosis;    Public health;    Mycobacterium tuberculosis;    Contact tracing;   

Others  :  1092877
DOI  :  10.1186/1745-6215-14-342

 received in 2013-03-22, accepted in 2013-10-11,  发布年份 2013

【 摘 要 】

Background

Tuberculosis is an infectious disease that continues to cause considerable morbidity and mortality globally. Only 65% of patients worldwide are currently diagnosed. Contact investigation is a strategy that aims to increase case detection and reduce transmission of tuberculosis, yet there is little evidence to show its effectiveness.

Methods/Design

We will conduct a cluster randomized controlled trial of contact investigation within the national tuberculosis control program of Vietnam. Household contacts of patients with smear-positive pulmonary tuberculosis will be invited to attend district tuberculosis units for symptom screening, examination, and chest radiography on four occasions over a two-year period. The primary endpoint is clinically confirmed tuberculosis among contacts during the 24 months of follow-up, ascertained using capture-recapture analysis. Microbiologically proven tuberculosis and treatment completion rates among contacts diagnosed with tuberculosis will be secondary endpoints. The incremental cost-effectiveness ratio will be estimated. The study will have 80% power to detect a 50% increase in the primary endpoint in the active intervention arm compared with the control arm. The study will include 8,829 contacts in each of the active screening and control groups, within 70 districts in 8 provinces in Vietnam, in both rural and urban settings.

Discussion

The effectiveness of contact investigation as a tool for improved tuberculosis case finding has not been established. This cluster randomized trial will provide valuable operational information for national tuberculosis programs in high-prevalence countries, in order to select the most cost-effective strategies to improve tuberculosis case detection.

Trial registration

The ACT2 study has been registered with the Australian New Zealand Clinical Trials Registry (ACTRN12610000600044).

【 授权许可】

   
2013 Fox et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]World Health Organization: Global Tuberculosis Control 2012. [http://www.who.int/tb/publications/global_report/archive/en/index.html webcite]
• [2]World Health Organization: Global Tuberculosis Control: Surveillance, Planning, Financing. [http://www.who.int/tb/publications/global_report/2007/en/ webcite]
• [3]World Health Organization: Global Tuberculosis Control 2011. [http://www.who.int/tb/publications/global_report/2011/en/index.html webcite]
• [4]Jassal MS, Bishai WR: Epidemiology and challenges to the elimination of global tuberculosis. Clin Infect Dis 2010, 50(Suppl 3):S156-S164.
• [5]Stop TB Partnership: The Global Plan to Stop TB 2011–2015. [http://www.stoptb.org/global/plan/ webcite]
• [6]Van’t Hoog AH, Laserson KF, Githui WA, Meme HK, Agaya JA, Odeny LO, Muchiri BG, Marston BJ, Decock KM, Borgdorff MW: High prevalence of pulmonary tuberculosis and inadequate case finding in rural Western Kenya. Am J Respir Crit Care Med 2011, 183:1245-1253.
• [7]Hoa NB, Sy DN, Nhung NV, Tiemersma EW, Borgdorff MW, Cobelens FG: National survey of tuberculosis prevalence in Viet Nam. B World Health Organ 2010, 88:273-280.
• [8]Zaman K, Hossain S, Banu S, Quaiyum MA, Barua PC, Salim MA, Begum V, Islam MA, Ahmed J, Rifat M, Cooreman E, Van Der Werf MJ, Borgdorff M, Van Leth F: Prevalence of smear-positive tuberculosis in persons aged ≥ 15 years in Bangladesh: results from a national survey, 2007–2009. Epidemiol Infect 2012, 140:1018-1027.
• [9]Uys P, Marais BJ, Johnstone-Robertson S, Hargrove J, Wood R: Transmission elasticity in communities hyperendemic for tuberculosis. Clin Infect Dis 2011, 52:1399-1404.
• [10]Lonnroth K, Corbett E, Golub J, Godfrey-Faussett P, Uplekar M, Weil D, Raviglione M: Systematic screening for active tuberculosis: rationale, definitions and key considerations. Int J Tuberc Lung Dis 2013, 17:289-298.
• [11]Waddington C, Egger D: Integrated Health Services - What and Why? Technical Brief No 1. Geneva: World Health Organization; 2008.
• [12]Fox GJ, Barry SE, Britton WJ, Marks GB: Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013, 41:134-150.
• [13]Fox GJ, Nhung NV, Sy DN, Lien LT, Cuong NK, Britton WJ, Marks GB: Contact investigation in households of patients with tuberculosis in Hanoi, Vietnam: a prospective cohort study. PLoS One 2012, 7:e49880.
• [14]Erkens CG, Kamphorst M, Abubakar I, Bothamley GH, Chemtob D, Haas W, Migliori GB, Rieder HL, Zellweger JP, Lange C: Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 2010, 36:925-949.
• [15]American Thoracic Society: Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000, 161:1376-1395.
• [16]Joint Tuberculosis Committee of the British Thoracic Society: Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000, 55:887-901.
• [17]Centers for Disease Control: Guidelines for the investigation of contacts of persons with infectious tuberculosis. MMWR Recomm Rep 2005, 54:1-47.
• [18]World Health Organization: International Standards for Tuberculosis Care: Diagnosis, Treatment, Public Health. The Hague: Tuberculosis Coalition for Technical Assistance; 2006.
• [19]Hopewell P, Pai M, Maher D, Uplekar M, Raviglione MC: International standards for tuberculosis care. Lancet Infect Dis 2006, 6:710-725.
• [20]World Health Organization: WHO Three 'I's Meeting: Intensified Case Finding, Isoniazid Preventive Therapy and TB Infection Control for People Living With HIV. [http://www.who.int/hiv/pub/tb/3is_mreport/en/index.html webcite]
• [21]Guyatt GHG, Oxman A, Vist G, Kunz R, Falk-Ytter Y, Alonso-Coello P, Schunemann H, The GRADE working group: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Brit Med J 2008, 336:924-926.
• [22]Fox GJ, Dobler CC, Marks GB: Active case finding in contacts of people with tuberculosis. Cochrane DB Syst Rev 2011, 9:CD008477.
• [23]Cavalcante SCDB, Barnes GL, Souza FB, Silva RF, Barroso PF, Mohan CI, Miller A, Golub JE, Chaisson RE: Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2010, 14:203-209.
• [24]Ayles HM, Sismanidis C, Beyers N, Hayes RJ, Godfrey-Faussett P: ZAMSTAR, The Zambia South Africa TB and HIV reduction study: design of a 2 × 2 factorial community randomized trial. Trials 2008, 9:63.
• [25]Obermeyer Z, Abbott-Klafter J, Murray CJ: Has the DOTS strategy improved case finding or treatment success? An empirical assessment. PLoS ONE 2008, 3:e1721.
• [26]Kranzer K, Afnan-Holmes H, Tomlin K, Golub JE, Shapiro AE, Schaap A, Corbett EL, Lonnroth K, Glynn JR: The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. Int J Tuberc Lung Dis 2013, 17:432-446.
• [27]Pocock SJ: Clinical Trials: A Practical Approach. New York: John Wiley & Sons; 1996.
• [28]Morrison J, Pai M, Hopewell PC: Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:359-368.
• [29]Hintze J: PASS 2008. NCSS, LLC. [http://www.ncss.com webcite]
• [30]Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, Small PM: Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999, 353:444-449.
• [31]Fok A, Numata Y, Schulzer M, FitzGerald M: Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. Int J Tuberc Lung Dis 2008, 12:480-492.
• [32]Kenyon TA, Valway SE, Walter WI, Onorato IM, Castro KG: Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. New Engl J Med 1996, 334:933-938.
• [33]Crampin AC, Glynn JR, Traore H, Yates MD, Mwaungulu L, Mwenebabu M, Chaguluka SD, Floyd S, Drobniewski F, Fine PE: Tuberculosis transmission attributable to close contacts and HIV status, Malawi. Emerg Infect Dis 2006, 12:729-735.
• [34]Buu TN, Van Soolingen D, Huyen MN, Lan NN, Quy HT, Tiemersma EW, Borgdorff MW, Cobelens FG: Tuberculosis acquired outside of households, rural Vietnam. Emerg Infect Dis 2010, 16:1466-1468.
• [35]Verver S, Warren RM, Munch Z, Richardson M, van der Spuy GD, Borgdorff MW, Behr MA, Beyers N, Van Helden PD: Proportion of tuberculosis transmission that takes place in households in a high-incidence area. Lancet 2004, 363:212-214.
• [36]Lienhardt C, Cobelens FG: Operational research for improved tuberculosis control: the scope, the needs and the way forward. Int J Tuberc Lung Dis 2011, 15:6-13.
• [37]Raviglione MC, Uplekar MW, Raviglione MC, Uplekar MW: WHO’s new Stop TB strategy. Lancet 2006, 367:952-955.
• [38]World Health Organization Stop TB Partnership Childhood TB Subgroup: Chapter 4: childhood contact screening and management. Int J Tuberc Lung Dis 2007, 11:12-15.